Atrial fibrillation is a type of cardiac arrhythmia (abnormal heart rhythm). Dogs with atrial fibrillation typically have a very fast heart rate that causes weakness, exercise intolerance, and eventually congestive heart failure. Treatments to slow down the heart rate improve a dog’s day to day quality of life. The goal of this study is to determine whether slowing down the heart rate also results in improved survival.
The study involves 4 to 5 visits to Penn Vet over the course of one year.
No prior treatment with doxorubicin
- Eligible dogs receive a discount for the cardiac evaluations performed at each study visit:
- Study covers 60% of echocardiogram fees
- Study covers 100% of ECG and 24-hour Holter monitoring fees
- Study covers 100% of cardiac biomarker blood test fees
- Clients are responsible for all other costs including physical examination, blood tests (apart from cardiac biomarkers), and other diagnostic tests (if recommended).
- Clients are responsible for the cost of all medications, including recommended heart medications.
Contact: Dr. Anna Gelzer